SELF-BREATHE RCT for Chronic Breathlessness (NCT04574050) | Clinical Trial Compass
CompletedNot Applicable
SELF-BREATHE RCT for Chronic Breathlessness
United Kingdom52 participantsStarted 2021-01-11
Plain-language summary
A feasibility RCT comprising two groups:
1. Intervention (SELF-BREATHE in addition to standard NHS care)
2. Control group (standard / currently available NHS care)
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults ≥ 18 years of age, with the ability to read and type in English
* Access to a computer, or tablet or smart phone, with internet access and the ability to email
* Chronic breathlessness (CB) defined as; breathlessness that persists (\>3months) despite optimal pharmacological treatment of the underlying disease including cancer, chronic obstructive pulmonary disease (COPD),asthma, interstitial lung disease (ILD), bronchiectasis, cystic fibrosis (CF) chronic heart failure (CHF), sickle cell disease, chronic renal/ liver failure or post COVID-19
* Chronic breathlessness at rest or on exertion; MRC dysponea score \>2
* Willing to engage with short-term self-guided internet-based breathlessness intervention (SELF-BREATHE)
* Able to provide informed consent
Exclusion Criteria:
* Breathlessness of unknown cause
* A primary diagnosis of chronic hyperventilation syndrome
* Currently participating in a rehabilitation programme, e.g. pulmonary/cardiac rehabilitation
What they're measuring
1
Feasibility: the number of patients recruited into this study over a 12-month period